FDA Inspection 1284704 — ADM Crosswind
The FDA completed an inspection of ADM Crosswind on June 2, 2026 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 2, 2026
- Fiscal Year
- 2026
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Topeka, KS (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 18219 | 21 CFR 507.25(b)(1) | Raw Material Controls |